Genome-wide analysis of antiviral signature genes in porcine macrophages at different activation statuses by Sang, Yongming et al.
Genome-Wide Analysis of Antiviral Signature Genes in
Porcine Macrophages at Different Activation Statuses
Yongming Sang1*, Wyatt Brichalli1, Raymond R. R. Rowland2, Frank Blecha1*
1Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America, 2Department of
Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America
Abstract
Macrophages (MFs) can be polarized to various activation statuses, including classical (M1), alternative (M2), and antiviral
states. To study the antiviral activation status of porcine MFs during porcine reproductive and respiratory syndrome virus
(PRRSV) infection, we used RNA Sequencing (RNA-Seq) for transcriptomic analysis of differentially expressed genes (DEGs).
Sequencing assessment and quality evaluation showed that our RNA-Seq data met the criteria for genome-wide
transcriptomic analysis. Comparisons of any two activation statuses revealed more than 20,000 DEGs that were normalized
to filter out 153–5,303 significant DEGs [false discovery rate (FDR) #0.001, fold change $2] in each comparison. The highest
5,303 significant DEGs were found between lipopolysaccharide- (LPS) and interferon (IFN)c-stimulated M1 cells, whereas
only 153 significant DEGs were detected between interleukin (IL)-10-polarized M2 cells and control mock-activated cells. To
identify signature genes for antiviral regulation pertaining to each activation status, we identified a set of DEGs that showed
significant up-regulation in only one activation state. In addition, pathway analyses defined the top 20–50 significantly
regulated pathways at each activation status, and we further analyzed DEGs pertinent to pathways mediated by AMP kinase
(AMPK) and epigenetic mechanisms. For the first time in porcine macrophages, our transcriptomic analyses not only
compared family-wide differential expression of most known immune genes at different activation statuses, but also
revealed transcription evidence of multiple gene families. These findings show that using RNA-Seq transcriptomic analyses
in virus-infected and status-synchronized macrophages effectively profiled signature genes and gene response pathways for
antiviral regulation, which may provide a framework for optimizing antiviral immunity and immune homeostasis.
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Introduction
Tissue macrophages (MWs) comprise a major category of
monocytic cells along with blood monocytes (BMs) and dendritic
cells (DCs). These cells originate from common monocytic
precursors de novo or differentiate from BMs [1]. MWs located in
tissues are subsequently polarized into various activation states that
are critical for defense responses and regulation of immune
homeostasis [1,2]. The activation status of monocytic cells can be
equated to the well-established Th1 and Th2 paradigm in T cells,
where MWs exist as classical M1 and alternative M2 statuses [2,3].
Four activation statuses of mature MWs have been well charac-
terized [2]. Classically activated or M1 MWs develop in response
to interferon (IFN)-c and bacterial products such as lipopolysac-
charides (LPS) [2–4]; the M2 status was originally ascribed to MWs
alternatively activated by Th2 cytokines interleukin (IL)-4 or IL-13
and is now the M2a subclass. The other subclasses of M2 MWs
include M2b, which is obtained by triggering Fcc receptors and
stimulation of Toll-like receptors (TLRs), and M2c, which is
derived from deactivation programs elicited by immunosuppres-
sive cytokines and hormones such as IL-10, glucocorticoids, (GC)
and transforming growth factor (TGF)-b [3–5].
Macrophages at the different activation statuses undergo
immunometabolic changes to differentially express a series of
intracellular markers and secretory cytokines/chemokines, which
have been linked to regulation of inflammation, tissue repair, T-
and B-cell proliferation, phagocytosis and antimicrobial activity,
primarily against bacteria and helminthes [4,5]. However, the
interaction between MW polarization and viral infection was
recently reported [6–9]. For example, HIV and respiratory
syncytial virus (RSV) have been shown to interact with MF
activation statuses and affect viral pathogenesis and host immune
responses [6–9]. Stimulation of type I IFN production is pivotal in
antiviral responses and leads to the establishment of a cell-
autonomous antiviral state (MaV) [10–14]. It is well established
that subsets of MFs and DCs are major producers of type I IFNs
[10,11]. Understanding the relationships between MF activation
statuses and antiviral states is critical to integrate the antiviral state
into the scenario of MF activation statuses, which have been
correlated with immune aspects of inflammation, tissue repair, and
overall antimicrobial activity [15–19].
Monocytic cells are vital innate immune cells in pigs that
provide early immune surveillance and bridge adaptive antiviral
immunity [20,21]; however, few studies have reported the
activation status of porcine monocytic cells or how cell activation
status relates to antiviral immunity [22,23]. This omission is
significant because many of the most economically important
porcine viruses are monocytotropic [17], including porcine
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reproductive and respiratory syndrome virus (PRRSV). PRRSV is
an ideal virus to use to decipher how monocytic cell activation
status interacts with antiviral immunity because it directly infects
subsets of MWs and DCs and subverts immune responses in these
cells [24–26]. Indeed, recent studies postulate that the pathogen-
esis of PRRS is dominated by the intriguing interplay of PRRSV
with monocytic cells [17,18,24–26]. Similar to other species,
porcine monocytic cells, and macrophages in particular, are
composed of diverse subgroups of cells with different activation
statuses, typically the M1, M2 and antiviral states polarized by
various mediators in vitro and in vivo [1–5]. These mediators,
including pathogen-derived molecules such as LPS and cytokines
IFNa/b, IFNc, IL-4, IL-13, IL-10 and TGF-b, dynamically skew
macrophages into diverse activation statuses in response to
different pathogenic agents. Classic studies of M1 (induced by
IFNc or LPS) and M2 (induced by IL-4 or IL-13) statuses have
been associated with regulation of inflammation, antimicrobial
and wound-healing processes; the M2c status induced by IL-10
and TGF-b is anti-inflammatory and was recently associated with
the retrieval of immune homeostasis [1–5]. In addition, cell
antiviral states in response to type I or type III IFNs have been well
studied upon viral infection but rarely investigated together with
other activation statuses such as in monocytic cells [5–14]. We
have provided evidence that the antiviral state could be
incorporated into the scenario of activation statuses, which
together provide a framework for optimizing antiviral immunity
and immune homeostasis in monocytic cells [18]. Because most
viral infections that target monocytic cells, such as PRRS, are
complicated with co-infection or secondary infection by pathogens
of other phyla [15–19], profiling gene response pathways reacting
to viral infection in macrophages at different activation statuses
may identify status-specific signature genes for antiviral and
immuno-homeostatic regulation. Here we have used a transcrip-
tomic shotgun sequencing (RNA-Seq) procedure in porcine MWs
at different activation statuses to study early gene responses to
PRRSV infection [27–34]. Our objectives were threefold: (1)
genome-wide profile differentially expressed genes (DEGs) in
PRRSV-infected MWs at different activation statuses, including an
antiviral state; (2) conduct a pathway analysis of immunometabolic
genes in MWs at different activation statuses altered by PRRSV
infection; and (3) identify various gene response pathways for
antiviral regulation. Notably, instead of a transcriptomic compar-
ison between infected and non-infected tissues/cells as reported in
previous studies [27–34], our focus was to examine the compar-
ative transcriptome in macrophages at different activation statuses
upon viral infection.
Materials and Methods
Animals and Isolation of Primary Cells
All virus and animal procedures were approved by the Kansas
State University Biosafety and Institutional Animal Care and Use
committees. Conventionally raised, 3- to 5-week-old clinically
healthy pigs from a herd without a history of virus infection were
used following procedures routinely used in our labs [35–38]. Four
pigs from one litter were used for collection of primary cells for
in vitro polarization experiments. The ANOVA Sample Size tool
(SigmaPlot11, Systat, San Jose, CA) was used to determine sample
size using an expected size (d) of 0.75, desired power (p) of 0.80
and an error level (a) of 0.05. Blood (20 ml/pig) was collected by
jugular venipuncture from anesthetized pigs. Immediately after
euthanasia, lungs were lavaged with 300 ml of 10 mM PBS
(pH7.4) [36–39]. Samples were placed on ice, and peripheral
blood mononuclear cells (PBMCs) and MFs were isolated from
the heparinized blood and lavage fluid, respectively, within 4 h
after collection. Lavage fluids were centrifuged at 4006g for
15 min to collect cells and further isolate MFs by plastic
adherence [36–39]. Cells were used immediately or cryopreserved
in Recovery cell culture freezing medium (Invitrogen, Carlsbad,
CA).
Cell Polarization and Viral Infection
Mediators and conditions for polarization of porcine monocytic
cells were applied as described [3–5,13,17]. In brief, MFs and
DCs were stimulated with the mediators of LPS, IFNc, IL-4, IL-
10, IFNa and IFNb at 20 ng/ml for 30 h (R&D Systems,
Minneapolis, MN). All mediators were dissolved in 16Dulbecco’s
phosphate-buffered saline (DPBS, Invitrogen) containing 1%
bovine serum albumin (BSA, Fraction V, cold-ethanol precipitat-
ed, Sigma-Aldrich, St. Louis, MO) and applied (1:100) to the
cultured cells; only BSA in DPBS was added to cultures of control
cells. Cells after polarization were infected with a PRRSV strain
(P129-GFP, AF494042) [36] at a multiplicity of infection (MOI) of
0.1 TCID50/ml for 5 h and washed twice with fresh culture
medium prior to RNA and protein extraction.
Transcriptomic Shotgun Sequencing
For RNA-Seq, equal quantities of primary alveolar macro-
phages from three pigs were polarized individually according to
procedures described above. Total RNA was extracted from
36107 cells of each activation status using a column-based RNA/
DNA/protein purification kit (Norgen Biotek, Ontario, Canada).
RNA integrity and concentration were evaluated with a Nano-
Drop 8000 spectrometer (NanoDrop, Wilmington, DE) and an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA)
to ensure RNA samples with A260/A280.1.8 and RNA integrity
number (RIN) .7.0 qualified for construction of sequencing
libraries. Messenger RNA purification, fragmentation, construc-
tion of sequencing libraries and sequencing were performed using
the Illumina Pipeline (BGI Americas, Cambridge, MA). Approx-
imately 25–30 M clean reads per sample were generated for
genome-wide transcriptomic analyses. The trimmed reads were
further assembled and mapped to the UniGene (http://www.ncbi.
nlm.nih.gov/UniGene/UGOrg.cgi?TAXID = 9823) and RefSeq
(http://www.ncbi.nlm.nih.gov/RefSeq/) collections by perform-
ing alignments using BWA software [31,33]. Using an edgeR
procedure, values of reads per kilobase per million mapped reads
(RPKM) were generated and used to identify the total number of
genes expressed in each porcine sample and DEGs among each
comparison [40]. The DEGs between two samples were analyzed
based on an algorithm as described [40]. In brief, the P-value
corresponds to a differential gene expression test where FDR
(False Discovery Rate) was used to determine the threshold of the
P-value in multiple tests. The functional classification of genes was
carried out through Gene Ontology and KEGG pathway analyses
using the DAVID web tool [41,42]. The dataset was deposited in
the NIH Short Read Archive linked to a BioProject with an
accession number of SRP033717.
Confirmation of DEGs using Real-time RT-PCR and a
Proteomic Analysis
Real-time RT-PCR assays were used to confirm two families of
DEGs revealed by the RNA-Seq protocol, namely the expression
of interferon-regulatory factor (IRF) and IL-17 families. Real-time
RT-PCR was performed as previously described [35–37]. Primers
used for RT-PCR assays are listed in Table S1. For confirmation
of DEG expression at the protein level, we used two-dimensional
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difference in gel electrophoresis (2D-DIGE, Applied Biomics, Inc.,
Hayward, CA). In brief, equal amounts (10 mg) of protein extracts
from 2–3 samples of the cells for RNA preparation were labeled
with a CyDye dilution (Cy2, Cy3 or Cy5, Amersham, Piscataway,
NJ), mixed and simultaneously separated on a single multiplexed
2D gel. After electrophoresis, the gel was scanned with a Typhoon
image scanner (GE Healthcare Bio-Sciences, Pittsburgh, PA) to
reveal protein spots with increased or decreased intensity
compared with the saline control sample. Differences in protein
expression were determined with minimum protein volume set at
200 and a 100% presence in all gel images. Only proteins with a
twofold or greater difference in protein expression among samples
and p-values ,0.05 (ANOVA) were defined as significant changes
and selected. Each spot was verified by manual comparison of
three sets of gels before being chosen from a preparative gel and
identified by nano LC-MS/MS (Applied Biomics). Scaffold
(Proteome Software Inc., Portland, OR) was used to validate
MS/MS-based peptide and protein identifications. Protein iden-
tifications were accepted if they could be established at greater
than 95% probability (assigned by the Protein Prophet algorithm
[43]) and contained at least two identified peptides. Genes of 16
randomly chosen proteins that showed a significant difference at
the protein level were identified from the RNA-Seq dataset for
comparison at the RNA level.
Antiviral Regulation based on Gene Response Pathways
Gene response pathways significantly altered by PRRSV
infection in MFs at different activation statuses were confirmed
for their involvement in antiviral regulation using agonists and
antagonists to modulate some pathways. Drugs used were
inhibitors of the cell epigenetic process, including azacytidine
DNA, BIX-01294 and Trichostatin A [44,45], as well as
modulators of AMP-kinase (AMPK) pathways, sodium salicylate
(SA) and U18666A [46,47]. Drugs were diluted in either dimethyl
sulfoxide (DMSO; cell culture grade, ATCC, Manassas, VA) or
cell culture medium and used to treat cells from 0.01 mM–10 mM
after the evaluation of non-significant cytotoxicity effects as
described [44–47]. Control cells were mock-treated with 0.01%
DMSO in culture medium. To evaluate their effect in antiviral
regulation, PRRSV infection was conducted simultaneously with
drug treatment for 24 h after the cells were washed twice with
culture medium [36]. We calculated virostatic effects with the
formula (Vt –Vi)/(Vt–V0), where Vt represents the value of total/
highest occurrence of a viral infection in mock-treated cells, Vi is
the value obtained from drug-treated cells, and V0 is the value
from cells without addition of viruses. In addition, viral infectivity
was examined after the viral preparation was incubated with the
drug solutions for 2 h prior to infecting cells to evaluate the direct
effect of drugs on the virus.
Data analyses. Relative gene-expression data of real-time
RT-PCR were normalized against Ct values of the housekeeping
gene (GAPDH), and the relative expression index (22DDCt) was
determined and compared with the base levels of control samples
[36,37]. Significance analyses pertaining to DEG annotation and
pathway analyses were conducted as described using a standard
analysis pipeline to determine the p-value corresponding to the
differential gene expression test and false discovery rate (FDR) and
reflect the p-value threshold in multiple tests [40–43]. Regulation
of antiviral activity was evaluated by percentage suppression of
viral propagation in cultured cells.
Results
Significant DEGs between PRRSV-infected MFs at
Different Activation Statuses
Standard analyses were conducted for quality control and to
ensure that RNA-Seq data met the criteria for genome-wide
transcriptomic analysis [48,49] (Figure S1 and Table S2). For
comparisons of any two activation statuses, we normalized
.20,000 DEGs and filtered out 153–5,303 significant DEGs
(FDR #0.001, fold change $2) in each comparison (Figure S1).
For example, the highest number of 5,303 significant DEGs was
revealed between M1-LPS and M1-IFNc cells, with 4,257 up-
regulated and 1,046 down-regulated, respectively, whereas only
153 significant DEGs were detected between M2-IL10 and mock-
stimulated MFs (defined as M0-PBS status) 5 h post-PRRSV
infection. Comparing the subtotal DEGs of each status with all
others showed that the M1-LPS status had the greatest number
(23,843) of significant DEGs, whereas the MaV-IFNa, M1-IFNc
and M2-IL4 statuses had 12,610, 14,965 and 15,005, respectively,
and the M2-IL10 and PBS-mock treated cells had the lowest
number (about 10,000) of significant DEGs (Figure S1). Therefore,
regardless of the overlap of common genes co-regulated at
different activation statuses during PRRSV infection, the activa-
tion statuses relevant to co-infection with helminthes (M2-IL4) or
bacteria (M1-LPS) had many more total DEGs than mock-
stimulated MFs upon PRRSV infection (Figure S1).
DEGs of other Statuses Compared with PBS Mock-
stimulated Cells and Potential Signature Genes for
Antiviral Regulation of each Activation Status
To simplify RNA-Seq data analysis for identification of gene
response pathways altered during PRRSV infection in MFs at
different activation statuses, we focused our comparisons of DEGs
from all five activation statuses on those from the M0-PBS cells.
Our combination of all significant DEGs versus the control cells
resulted in 6,624 non-redundant genes that were significantly
down- or up-regulated in one or several groups of cells at different
activation statuses post-PRRSV infection. To profile potential
signature genes for antiviral regulation relevant to MF activation
statuses, we clustered DEGs of only those that were significantly
up-regulated in each or two activation statuses; for example, we
identified 44 and 72 significant DEGs that were up-regulated only
in M1-IFNc and IFNa-antiviral (MaV) states, respectively (Fig. 1).
These potential marker genes include some known genes such as
CD101, purinergic receptor (P2RY13), vanin 1 (VNN1), and IFN-
induced transmembrane protein 1 (IFITM1) as well as unknown
transcripts; however, most of these genes have not been studied for
their regulation of activation statuses and antiviral immunity
(Fig. 1, and data not shown).
Differential Expression of Transcription Factors (TFs) in
Multiple Families and Confirmation of RNA-Seq Data
Members of transcription factors in multiple families were
identified among DEGs that were significantly regulated at
different activation statuses compared with mock-stimulated cells.
These transcription factors are in families, such as the suppressor
of cytokine signaling (SOCS), Kruppel-like factor (KLF), perox-
isome proliferator-activated receptor (PPAR), IFN regulatory
factor (IRF) and signal transducer and activator of transcription
(STAT), which have been reported to be important in mediation
of cell activation and antiviral activity in monocytic cells [50–55].
Further curation of the non-filtered DEG datasets (including both
significant and non-significant) revealed family-wide coverage of
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all transcription factors and their differential expression at certain
activation statuses post-PRRSV infection. In mice, the develop-
mental bias toward M1-like and M2-like macrophages was
associated with the deficiency of Socs2 and Socs3, respectively
[50]. Here we showed that the porcine SOCS2 gene was most
down-regulated in the M1-LPS status. In contrast, the SOCS3 gene
was suppressed in the M2-IL4 status 2- to 18-fold compared with
expression levels at other statuses (Fig. 2A). In addition, we showed
that SOCS1 was dramatically suppressed in the M1-LPS statuses
[51], and SOCS4 and SOCS5 were particularly suppressed in the
M1-IFNc status. KLFs, such as KLF2 and KLF4, are another
group of transcription factors involved in regulation of inflamma-
tory status of macrophages in humans and mice [52,53]. We found
that porcine KLF4, KLF7, KLF9 and KLF13 were particularly up-
regulated in the M2-IL4, M1-LPS, M2-IL10 and M1-IFNc
statuses, respectively. In contrast, dramatic suppression of KLF8,
KLF9 and KLF13 was associated with the M1-LPS status post-
PRRSV infection (Fig. 2B). These findings indicate that multiple
KLFs may be involved in regulation of the activation status
relevant to antimicrobial activity [53].
Figure 1. RNA-Seq analysis of DEGs in polarized MFs compared with sham control MFs in PBS post-PRRSV infection. The heatmaps of
6,624 significant DEGs (left) and numbers of potential signature genes were grouped based on significant up-regulation in only one activation status
or co-stimulated in two activation statuses (see table at right, and the supplemented results of DEG statistics in Table S2). FDR (false discovery rate)
#0.001, fold change $2 for DEG significant determination. The color scale under the heatmap illustrates the log2 (fold change) values shown in the
heatmap.
doi:10.1371/journal.pone.0087613.g001
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Members of IRFs are implicated in the regulation of a variety of
biological processes, including interferon production and modu-
lation of immune cell differentiation [54]. Along with the role of
IRF1 and IRF8 in macrophage differentiation, IRF4 and IRF5
have recently been associated with M2-IL4 and M1 statuses,
respectively, in murine macrophages [3–5]. Our RNA-Seq data
showed that porcine IRF1 was highly stimulated in both M1-IFNc
and M1-LPS statuses, and IRF8 was stimulated only in M1-IFNc.
Porcine IRF4 had comparatively constitutive expression but a
higher stimulation in the M2-IL4 status than in any other status;
similar constitutive expression of IRF5 was found but dramatic
suppression in the M1-LPS status (Fig. 3C). In addition to IRF5,
porcine IRF2, IRF3, IRF7, IRF8 and IRF9 were suppressed more
in the LPS-M1 cells than in cells at other activation statuses;
however, most were up-regulated in cells at both MaV-IFNa- and
M1-IFNc states. Our RNA-Seq reads also revealed two novel co-
repressor molecules for porcine IRF2, IRF2BP1 and IRF2BP2
[55]. Despite being relatively constitutively expressed in macro-
phages of all tested statuses, corresponding suppression of either
IRF2BP1 or IRF2BP2 was observed with M1-IFNc and MaV-
IFNa statuses, respectively, in which statuses IRF2 had the highest
stimulation (Fig. 2C).
To confirm our RNA-Seq expressional analysis, we used real-
time RT-PCR assays to re-analyze the expression of porcine IRF
genes using RNA aliquots frozen at 280uC. The general
expression pattern of all IRF genes, particularly differential
expression levels in macrophages at activation statuses different
from the PBS-mock control, matched well with the RNA-Seq data
(Fig. 2C and 2D). To verify the differential expression of genes at
the protein level, we used a 2D-DIGE procedure to isolate protein
Figure 2. Transcriptomic analysis of selected transcription
factor (TF) families. Members of these TF families have been shown
to be critical to the regulation of activation status and antiviral activity
in murine monocytic cells. Differential expression of TF families of (A)
suppressors of cytokine signaling (SOCS), (B) Kruppel-like factors (KLF),
and (C) interferon regulatory factor (IRF) in polarized MFs upon PRRSV
infection are shown. (D) The differential expression of IRF family was
verified with a real-time RT-PCR assay (the Y-axis scale indicating fold
change to M0-PBS). The color scale under each heatmap illustrates the
midpoint and range of reads per kilobase per million (RPKM) values of
listed transcripts.
doi:10.1371/journal.pone.0087613.g002
Figure 3. Verification of DEGs at the protein level using a
proteomic procedure. Equal amounts of protein from macrophages
at different activation statuses were stained with either red or green
fluorescent dyes and co-resolved using a 2D-DIGE procedure (Applied
Biomics, Inc., Hayward, CA) to isolate protein spots that significantly
increased in macrophages at certain activation statuses and to further
identify the isolated proteins by nano LC-MS/MS. Of 16 significantly
increased protein spots randomly selected across four activation
statuses (black bars) compared with the M0-PBS status (the white
bars), 12 (75%) protein spots (WARS, PLEK, RAN, CKB, PLOD3, RNF114,
HNRNPU, ATP6V1E1, CANX, MX1, MX2, H2B3A) also showed significant
up-regulation at the RNA level, with the other four (SND1, ANXA1,
UBE2D3 and MPP5) showing a significant increase only at the protein
level. *, FDR #0.001 of gene expression and protein ratio $2. The
number before each gene symbol along the X-axis indicates the protein
spot mapped in the gel shown in Figure S2. Gene symbol abbreviations:
SND1, staphylococcal nuclease domain-containing protein 1; WARS,
tryptophanyl-tRNA synthetase; PLEK, pleckstrin; RAN, Ras-related GTP
binding C; CKB, creatine kinase B-type; PLOD3, procollagen-lysine, 2-
oxoglutarate 5-dioxygenase 3; RNF114, RING finger protein 114;
HNRNPU, heterogeneous nuclear ribonucleoprotein U; ANXA1, annexin
A1; ATP6V1E1, v-type proton ATPase subunit E 1; UBE2D3, ubiquitin-
conjugating enzyme E2 D3; CANX, calnexin; MX, myxovirus resistance
gene; H2B3A, histone H2B3A; MPP5, membrane protein palmitoylated
5.
doi:10.1371/journal.pone.0087613.g003
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spots significantly increased in macrophages at certain activation
statuses and further identified the isolated proteins by nano LC-
MS/MS. Of 16 proteins randomly selected across the four
activation statuses, 12 (75%) showed significant up-regulation at
both protein and RNA levels, with the other four showing a
significant increase only at the protein level (Fig. 3 and Figure S2).
Gene Response Pathways Significantly Regulated in MFs
at Different Activation Statuses upon PRRSV Infection
To evaluate the biological and ontological importance of the
significant DEGs among different activation statuses, we per-
formed pathway analysis of the DEGs predominately based on the
KEGG database (http://www.genome.jp/kegg/). Compared with
control cells, significant DEGs in the cells at each activation status
were assigned to more than 210 pathways except for the M2-IL10
status, which had the fewest DEGs assigned to 100 pathways.
Among these pathways, 20–50 pathways in the cells of each
activation status were significantly (p and FDR ,0.05) enriched by
significant DEGs. Most of these pathways belong to immune
regulation, antimicrobial response, metabolism and the cytoskel-
eton system as well as cell development and movement. Figure 4
lists 17 differential pathways that may be important in regulation
of macrophage immune function against PRRSV and co-
infections. In addition to these pathways, others including
chemokine signaling, complement cascade and apoptosis, which
exhibited differential responses between PRRSV-infected and
non-infected tissues and were previously discovered using gene
array-based techniques [27–34], we showed that the pathways for
antigen processing and presentation, cytokine-cytokine receptor
interaction, chemokine signaling and Toll-like receptor (TLR)
signaling were among the top immunomodulatory pathways
affected by macrophage polarization and that they responded
differently to PRRSV infection. The RIG-I-like receptor signaling
pathway, which is involved in detection of viral dsRNA during
viral replication, was significantly regulated only in cells in the
MaV-IFNa state. Correspondingly, the pathways closely relevant
to antimicrobial activity, including phagosome, lysosome and
antimicrobial reaction against viruses, bacteria and parasites, were
significantly regulated. However, pathways related to antiviral
response, such as viral myocarditis and natural killer cell–mediated
cytotoxicity, were significantly regulated only in cells at two IFN-
stimulated statuses, and the regulation of the lysosome pathway,
which is critical for bactericidal activity, was prominent only in the
M1-LPS status. In contrast, the apoptotic pathway was not
significantly regulated and minimally affected in cells at both IL10-
regulatory and MaV-IFNa statuses, suggesting potential anti-
apoptotic activity during the early phase of PRRSV infection [33].
Metabolic pathways, such as lipid metabolic pathways, were
prominently affected in PRRSV-infected macrophages at different
activation statuses. LPS-M1 status in particular was more
dramatically altered in metabolic pathways, implying synergistic
effects of co-infection signaling from PRRSV and bacterial LPS
(Fig. 4).
AMP-activated Protein Kinase (AMPK) Pathway and
Epigenetic Regulation are Novel Targets for Anti-PRRSV
Regulation
AMPK consists of a catalytic a subunit and regulatory b and c
subunits, and plays a key role as a master regulator of cellular
energy homeostasis through sensing the intracellular AMP:ATP
ratio [46,47]. AMPK activation positively regulates signaling
pathways that replenish cellular ATP supplies, including fatty acid
oxidation and autophagy, and negatively regulates ATP-consum-
ing biosynthetic processes including gluconeogenesis, lipid and
protein synthesis. Because of the discovery of significant modula-
tion of multiple metabolic pathways, particularly lipid/fatty acid
metabolism downstream of AMPK-signaling, we sought to
annotate the AMPK pathway in detail. As shown in Fig. 5, of
22 genes at the center of AMPK signaling, most were within the
list of significant DEGs (Fig. 5A). Dramatic differences were
detected between M1 and M2 statuses. As illustrated in Fig. 5B, 13
of the AMPK and AMPK-regulated genes were significantly
down-regulated in cells at the LPS-M1 status; in contrast, most
were significantly up-regulated in the IL4-M2 status. Consequent-
ly, we observed differential regulation of multiple lipid metabolic
pathways during pathway analysis (Fig. 4). Because AMPK
signaling is critical for immunometabolic regulation and has not
been implicated in antiviral response against PRRSV infection, we
further validated the involvement of the AMPK-mediated
pathway in anti-PRRSV response using agonists of AMPK-
signaling. As shown in Figure S3, both AMPK activators, salicylate
(SA) and U18666A, significantly suppressed PRRSV infection in
MARC-145 and porcine monocyte-derived dendritic cells (mDCs)
at the tested doses without causing detectable cytotoxicity [46].
In addition to the AMPK-signaling pathway, annotation of
DEGs in our RNA-Seq data revealed family-wide differential
expression of genes involved in epigenetic regulation, which is
defined as non-genetic alterations critical to biological adaptability
to environmental stimuli. Epigenetic traits are tightly regulated by
two major epigenetic modifications: chemical modifications to the
cytosine residues of DNA (DNA methylation) and histone proteins
associated with DNA (histone modifications) [44,45]. Studies of
epigenetic regulation to potentiate antiviral responses have
recently emerged [56]. We showed that multiple genes encoding
enzymes responsible for catalyzing epigenetic regulation, including
DNA methyltransferases, histone methytransferases, histone de-
methylases and histone deacetylases, were significantly differen-
tially expressed in PRRSV-infected MFs polarized at different
activation statuses. Expression of multiple genes important to
epigenetic regulation increased significantly at the M2-IL4 status
and decreased at the M1-LPS status, which included DNA
methylatransferase genes DNMT3A and DNMT3AL, the histone
methyltransferase-related genes ASH1, EHMT1, EHMT2, EZH1,
MLL3, MLL4, SETD1A, SETD8 and SUV420H2, as well as
HADC2, HADC9(9L), SIRT1 and KDM2A genes responsible for
other histone modification processes (Fig. 6A). Because we
previously showed that the M2-IL4 status of porcine macrophages
was associated with a moderate increase in PRRSV infection, we
investigated whether epigenetic mechanisms could be exploited for
anti-PRRSV regulation in cells permissive to PRRSV infection. As
shown in Fig. 6B, using dosages that did not cause detectable
cytotoxic effects (data not shown), inhibitors of DNA methytrans-
ferases (azacytidine DNA), histone methytransferases (BIX-01294)
and particularly histone deacetylases (Trichostatin A), were all
effective in suppressing PRRSV infection in both porcine
macrophages and, in particular, MARC-145 cells. Although 40–
60% suppression in PRRSV infection was found in porcine
primary macrophages, more than 90% suppression of PRRSV
infection was observed using various epigenetic inhibitors in the
MARC-145 cells (Fig. 6B).
Discussion
Porcine reproductive and respiratory syndrome (PRRS) remains
one of the most globally devastating swine diseases and a challenge
to both porcine immunology and vaccinology [17,24–26]. The
viral etiology of PRRS, PRRSV, is an enveloped RNA virus with a
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high mutation rate and capability of evading porcine immune
responses [17,18,24–26]. The primary infection routes of PRRSV
are respiratory and reproductive tracts, where monocytic lineage
cells, particularly subsets of MFs (alveolar and intravascular) and
DCs (inflammatory monocyte-derived mDCs), are highly permis-
sive to the virus [24–26]. Direct infection plus other mechanisms
enable PRRSV to subvert critical immune responses exerted by
monocytic cells, which include suppressing cell antiviral signaling,
diverting cytokine production and action, directing cytolysis,
suppressing phagocytic and microbicidal activity, as well as
reducing antigen presentation to T cells [17,18,24–26]. This
innate immune aberration further leads to inefficiency in bridging
adaptive immunity, which jointly causes immunosuppression of
primary PRRSV infection as well as co-infections or secondary
infections by other pathogens [17]. Clearly, monocytic cells play a
dominant role in PRRSV pathogenesis. Thus, profiling signature
genes and gene response pathways in functional subsets of porcine
monocytic cells is critical for understanding leukocyte biology and
Figure 4. Pathway analysis of DEGs was annotated against the KEGG database. A p-value and FDR of ,0.05 in the two-sided Fisher’s exact
test were considered significant. Selected pathway categories are shown along the vertical axis, and the horizontal axis represents the log10 (p value)
of these pathways showing the significant difference among cells at different activation statuses.
doi:10.1371/journal.pone.0087613.g004
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Figure 5. AMPK-mediated pathways for antiviral regulation. (A) Heatmap of the subset DEGs in the AMP-kinase pathway, which is critical to
control of lipid metabolism, are shown. (B) As illustrated in the pathway, most key genes in the M1 statuses (IFNc- or LPS-induced) or IFNa-antiviral
state (MaV) were differentially regulated, leading to a general suppression of lipid metabolism in contrast to a general increase in the M2-IL4 status. In
addition, the illustration of AMPK-mediated pathways in other statuses is presented in Figure S3 together with the dose-dependent suppression of
PRRSV infection by two AMPK-pathway activators. Legend: green-line box, significant suppression; blue-line box, non-significant suppression; red-line
box, significant up-regulation; yellow-line box, non-significant up-regulation; and black-line box, non-significant detection. p (FDR) ,0.001, fold
change $2 for significant determination.
doi:10.1371/journal.pone.0087613.g005
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searching gene-targeted measures to control monocytotropic
infections [17] by pandemic pathogens including PRRSV.
Using a laboratory-attenuated PRRSV strain [35], we investi-
gated the early gene response (5 h post-infection) in porcine
macrophages at activation statuses polarized in vitro. During
interaction with the virus in this early phase, macrophages
maintained their original polarization and cell integrity without
any observed loss of viability, which allowed us to investigate the
early immunometabolic responses prior to cellular exhaustion by
viral replication and release. RNA-Seq instead of a microarray
procedure was chosen based on the maturity of this next-
generation sequencing procedure and the potential to detect
unidentified transcripts [48,49]. Although previous studies have
used gene-array or RNA-Seq techniques to perform genome-wide
transcriptomic analyses in PRRSV-infected tissues or primary cell
collections [27–34], our study is the first to investigate antiviral
responses in synchronized macrophage subsets. In addition,
pathway analysis using profiled DEGs in synchronized macro-
phages revealed discoveries that possibly were masked in multiple
cell types in tissues and would be necessary for in vivo antiviral
regulation targeting monocytic cells. Furthermore, we verified that
some gene response pathways could be exploited as potential
targets for antiviral regulation, which, to our knowledge, has not
been validated by previous reports relevant to genome-wide gene
mapping of anti-PRRSV responses [27–34].
RNA-Seq analyses have been reported to require more than
18M reads for each sample to reach a saturated state for novel
gene discovery and expressional analysis [48,49]. To meet this
criterion for genome-wide transcriptomic analysis, we obtained
approximately 30M reads for each sample with .99% clean
reads; the majority could be mapped to current gene or genome
databases. Indeed, our quality control assays, including saturation
analysis as well as distribution and coverage analyses in reference
genes and genomic scaffolds, displayed an RNA-Seq dataset well
Figure 6. Epigenetic mechanisms for antiviral regulation. (A) RNA-Seq analysis of DEGs encoding key enzymes in epigenetic regulation. The
heatmaps display family-wide collections of genes encoding DNA/histone methyltransferases, histone deacetylases and histone demethylases. In
addition to differential expression analysis, these data also revealed family-wide transcription evidence of most of these porcine epigenetic genes at
the mRNA level for the first time. (B) Suppression of PRRSV infection by epigenetic inhibitors at optimized concentrations in MARC-145 cells and
porcine MFs. The fluorescent micrographs (inset) show infected cells using a DsRed-labeled PRRSV, whereas the larger bright-field images show cell
phenotypes of non-visible cytotoxic effects. The micrographs represent one of three replicates. Summary data are presented below the images.
doi:10.1371/journal.pone.0087613.g006
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qualified for cross-sample transcriptomic analysis (Figure S1).
Bioinformatic analyses of DEGs revealed thousands of significantly
differentially expressed genes in cells at different activation
statuses. As expected, viral infection in cells at M1-LPS and M2-
IL4 statuses, which mimicked the co-infection stimuli of a virus
with bacteria or helminthes, respectively, had the greatest number
of DEGs (Fig. 2 and Figure S1). The significantly lower and
comparable DEG numbers in both M2-IL10 and PBS non-
stimulated statuses are in agreement with the immune homeostatic
regulation role of the M2-IL10 status and the relatively naı¨ve
status of our primary cells without stimulation (Fig. 2 and Figure
S1) [2–5].
Compared with the M0-PBS cells from the mock stimulation,
we identified 6,624 DEGs that were significantly up- or down-
regulated in cells at five activation statuses. To profile signature
genes with potential as markers for phenotyping macrophages and
antiviral regulation, the status-specific up-regulated genes related
to each activation status post-PRRSV infection were clustered.
Ten to several hundred significant DEGs that were up-regulated at
only one or two statuses were pooled. Preliminary identification of
these potential signature genes identified some known genes and
unknown transcripts up-regulated in M1-IFNc and MaV-IFNa
statuses. Most of these genes could be candidates but remained
elusive in regulation of antiviral immunity and activation statuses.
Only nine potential signature genes were identified for the M2-
IL10 cells, which were at a regulatory status and may be critical to
restore immune homeostasis after infection (Fig. 2) [2–5].
Transcription factors, including members of IRF, SOCS and
KLF families, have been implicated in the regulation of
development and activation process of monocytic cells in humans
and mice [53–57], but they have been seldom studied in pigs.
Family-wide coverage of multiple families of transcription factors
were scrutinized using our RNA-Seq reads. This approach not
only provided transcriptomic evidence of these porcine genes, but
also allowed cross-species immunogenetic comparison. For exam-
ple, murine orthologs of SOCS2, SOCS3, KLF2, KLF4, IRF4
and IRF5 have been implicated in regulation of monocytic cell
activation [51–55]. Our DEG analyses among cells at different
activation statuses showed that porcine orthologs of these
transcription factors may conserve their role in regulation of
macrophage activation. Our transcriptomic data also revealed that
some other members of these transcription factors could play
significant roles in macrophage development and activation, which
include SOCS1, KLF7, KLF9, KLF13 and IRF2 being specifically
down-regulated at the LPS-M1 status as well as KLF9 significantly
up-regulated only at the IL10-regulatory status. The family-wide
profile of multiple gene families indicated that the quality of our
RNA-Seq data fulfilled the criteria for genome-wide transcrip-
tomic analysis. Following suggested procedures, we verified IRF
expression by RT-PCR assay and matching the general expression
patterns over IRF expression in porcine macrophages at different
activation statuses. Furthermore, we verified the expression of 16
randomly chosen genes at the protein level, showing that most
were in agreement at both protein and RNA levels (Fig. 2D and
Fig. 3). Four genes showed a significant increase at only the protein
level, suggesting that some gene stimulation was regulated through
enhancing translation efficiency rather than increasing new
transcripts (Fig. 3 and Supplement Fig. S2).
Pathway analyses of significant DEGs based on the KEGG
database clustered them into 5–30 pathways significantly regulated
at each activation status compared with the control. The M2-IL10
status had only five pathways that were significantly regulated
compared with more than 20 in cells at other activation statuses
during the early phase of PRRSV infection. These five significant
pathways of the M2-IL10 status regulate toward homeostatic
retrieval and may represent the essential responses of porcine
macrophages to PRRSV infection. Antigen processing and
presentation was the most significant pathway regulated in
PRRSV-infected macrophages at both IFNc-M1 and IFNa-
MaV states, indicating that macrophages at these two states were
adapted for stimulation of both innate and adaptive immunity
[10–13]. Macrophages at the LPS-M1 status had most the
pathways involved in immune and antimicrobial regulation, and
metabolic pathways, in particular, were significantly regulated the
most in this status post-PRRSV infection. This finding implies that
more profound responses were regulated by stimuli from bacterial
and viral co-infection. Notably, our RNA-Seq data using PRRSV-
infection of synchronized macrophages revealed many more
pathways potentially associated with PRRSV infection, which
includes significant pathways elucidated previously by microarray
procedures, including antigen processing and presentation, Toll-
like receptor signaling, complement and coagulation cascades and
chemokine signaling pathways (Fig. 4) [27–34].
Two other pathways, which we annotated in detail and verified
their involvement in antiviral responses against PRRSV infection,
were the AMPK-mediated pathway and the epigenetic regulation
pathway [44–47]. The multi-subunit AMP-protein kinase, which
senses cellular energy status, is a key regulator in mediating many
metabolic and stress response pathways, including fatty acid
metabolism and oxidation, lipid metabolism, p53-mediated
signaling and mammalian target of rapamycin (mTOR) signaling
for protein synthesis [46,47]. Of these pathways, the lipid/fatty
acid metabolism–related pathways were significantly enriched in
our pathway analysis. Detailed annotation of the upstream genes
mediating AMPK activity and the downstream genes regulated by
AMPK identified dramatic differential expression of genes in the
AMPK pathway, in particular between the cells at other statuses
compared with the M2-IL4 status (Fig. 5). Although antiviral
regulation through modulation of AMPK-mediated pathways was
recently reported [46,47], the direct involvement of AMPK
signaling in PRRSV infection has not been studied. Our further
functional validation clearly indicated that anti-PRRSV activity
can be elicited through drugs that modulate AMPK signaling
(Fig. 5). Immunometabolism is a new front at the interface of
immunology and metabolism that focuses on the integration and
interaction of immune and metabolic systems in mediation of the
development of diseases [57]. The regulation of AMPK-signaling
and potential downstream lipid metabolism may posit new
strategies for potentiating antiviral responses and for optimizing
current vaccine strategies against PRRSV infection.
Epigenetic regulation, which involves chemical modification of
DNA cytosine residues and DNA-bound histone proteins without
alteration of DNA sequence, is emerging as one of the major
factors regulating gene expression in response to environmental
stimuli [44,45]. Recent studies have demonstrated that epigenetic
mechanisms have the potential to mediate activation status,
including the antiviral state in monocytic cells. For example,
dimethylation of histone H3 at lysine 9 (H3K9me2) has been
shown to elicit suppression of IFN and IFN-inducible antiviral
gene expression [56]. On the basis of family-wide annotation and
DEG analysis of genes pertinent to epigenetic regulation, our
RNA-Seq data identified more than a dozen epigenetic genes that
were strikingly differentially expressed in PRRSV-infected mac-
rophages at different activation statuses. Indeed, suppression of
DNA and histone methylation, and particularly histone deacetyla-
tion, effectively inhibited PRRSV infection in cells.
In summary, in addition to identifying potential signature genes
(Fig. 1, 2), our pathway analysis discovered multiple pathways
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(Fig. 4–6) significantly involved in response to PRRSV infection in
macrophages at different activation statuses. It is noteworthy that
our RNA-Seq analysis using polarized macrophages revealed a
dozen more significant pathways that have not been reported in
previous transcriptomic analyses using PRRSV-infected tissues or
cells [27–34]. Furthermore, analysis of two key signaling pathways,
AMPK-mediated and epigenetic mechanisms, not only clustered
the pathway-inclusive DEGs pertaining to each activation status,
but also functionally validated the involvement of AMPK-
mediated and epigenetic pathways in regulation of antiviral
response to PRRSV infection in cells. The major gene response
pathways and functional determination of potential signature
genes discovered here may lead to pathway-targeted design of
better adjuvants for current vaccines and elicit the discovery of
therapeutic measures using monocytic cells manipulated for
antiviral propensity [17].
Supporting Information
Figure S1 (A) Quality control/assurance analyses of
RNA-Seq reads. Shown are diagrams of the statistics of raw
reads, of which .99% are clean reads, and the distribution of
genes’ coverage. Both diagrams represent analyses of the RNA-
Seq data from the control sample (M0-PBS, see abbreviation
below), which are comparable among all samples of MFs at
different activation statuses (also see the supporting results of DEG
statistics under the title of Table S2). (B) Statistics of differentially
expressed genes [DEGs, FDR (false discovery rate) #0.001 and
log2 Ratio $1] detected compared in each pair of samples.
Abbreviations: M0-PBS, MFs mocked-treated with phosphate-
buffered saline (PBS); M1-IFNc, MFs at M1 status stimulated with
IFN-c; M1-LPS, MFs at M1 status stimulated with LPS; M2-IL4,
MFs at M2 status stimulated with IL-4; M2-IL10, MFs at M2
status stimulated with IL-10; and MaV-IFNa, MFs at antiviral
status stimulated with IFN-a.
(TIF)
Figure S2 Verification of DEGs at the protein level
using a proteomic procedure. Equal amounts of proteins
from macrophages at different activation statuses were stained
with either red or green fluorescent dyes and co-resolved using a
2D-DIGE procedure (Applied Biomics, Inc., Hayward, CA) to
isolate protein spots that significantly increased in macrophages at
different activation statuses and to further identify isolated proteins
by nano LC-MS/MS. The analytic 2D-DIGE gel is shown with
overlapping protein samples from cells at both M1-IFNc and M0-
PBS statuses.
(TIF)
Figure S3 (A-C) Illustration of DEGs in AMPK-mediated
pathways in M1-IFNc, M2-IL10, and MaV-IFNa activa-
tion statuses, respectively. Color legends of the boxes
framing gene symbols are shown as in Figure 5. (D & E)
Suppression of PRRSV infection by two AMPK-pathway
activators, salicylic acid (SA) and U18666, at physiological
concentrations in MARC-145 cells and porcine monocyte-derived
dendritic cells (mDCs). The fluorescent micrographs (inset) show
cells infected by a GFP-labeled PRRSV, whereas the larger bright-
field images show cell phenotypes with non-visible cytotoxic
effects. The micrographs represent one of three replicates with
similar results.
(TIF)
Table S1 PCR primers used for RT-PCR assay of
porcine IRF and IL-17 genes.
(DOCX)
Table S2 Collective results of sequencing assessment
for quality control of the RNA-Seq data to meet the
criteria for genome-wide transcriptomic analysis.
(PDF)
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